Sat, Mar 17, 2018
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
New Managers January 2012

Hedge fund industry players discuss emerging managers


In the last quarter (Q4-2011), Opalesque recorded a lot of commentaries coming from the hedge fund industry on what new hedge fund managers should and should not do, the problems they are encountering, the opportunities that are awaiting, and generally what's in store for them. Here are a few snippets of the "global conversation" about our hopeful start-ups.

Trends in LatAm, in boutiques

While some of our communicators see a trend in funds being launched in LatAm, others see a return to investing in boutiques.

Most new managers global law firm Walkers has seen come from established hedge funds, others from banks. Setting up with $10m or $20m is no longer popular, as more capital is needed to survive. Thankfully, many managers are getting significant amounts of seed capital now. Walkers also sees a trend in the growth of funds launched by managers in South America, particularly Brazil and Chile. The law firm, which has a group there now, expects more activity there from now on.

A trend that Alexandre Col noted is the renewed interest in boutiques. He is the head of investment funds at Geneva-based Banque PrivÃe Edmond de Rothschild. As a fund of hedge funds manager (FoHFs), he used to be in favour of investing in large hedge funds because they attracted talents, he said. Even more so after '08. However, today, he is looking at new managers, at diversifying his portfolio and building a niche strategy. Now is the right time for that, he thinks.

Here is some advice for you

At a conference, several investors and FoHFs managers discussed what a new fund needs to do to ......................

To view our full article please login

This article was published in Opalesque's New Managers a top-down monthly analysis, news and research publication on the global emerging manager space.
New Managers
New Managers
New Managers

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Performance - Hedge fund mojo is back with investor hopes at six-year high, These hedge funds produce the most consistently great results[more]

    Hedge fund mojo is back with investor hopes at six-year high From Hedge funds on the heels of a surprisingly strong performance in 2017 are raising hopes for an encore. Investors expect their managers to return 8.5 percent in 2018, according to a Credit Suisse Group AG sur

  2. Investing - Hedge funds amass big bets against world's leading advertisers, Investor Elliott Management buys tiny stake in Wipro[more]

    Hedge funds amass big bets against world's leading advertisers From Hedge funds have amassed bearish bets of more than $3bn against the world's largest advertising companies in an attempt to profit as the industry undergoes ongoing wrenching disruption and slowing growth. Funds i

  3. News Briefs - Investcorp to launch a $100 million PE fund for Omani pension funds[more]

    Bahrain-based investment firm Investcorp will soon launch a $100 million fund dedicated to Oman's Pension Funds as part of its investment plan. 'The Opportunities Fund' will be focused on private equity investments in the U.S. and Europe and will target mid-sized companies across a broad range of se

  4. DoubleLine's Gundlach sees U.S. 10-year Treasury yield rising, weighing on stocks[more]

    From Reuters/ Jeffrey Gundlach, the chief executive of DoubleLine Capital and known on Wall Street as the "Bond King," said on Tuesday the yield on the U.S. 10-year Treasury note will likely move higher and pressure riskier assets including equities and junk bonds. Gundlach, on an

  5. SEC charges Theranos CEO Holmes with fraud[more]

    Bailey McCann, Opalesque New York: The SEC has charged Elizabeth Holmes, founder and CEO of Theranos and its former President Ramesh "Sunny" Balwani with raising more than $700 million from investors through an elaborate, years-long fraud in which they exaggerated or made false statements about t